Cargando…
Auxotrophic Mycobacterium bovis BCG: Updates and Perspectives
Mycobacterium bovis BCG has been used for a century as the only licensed vaccine against tuberculosis. Owing to its strong adjuvant properties, BCG has also been employed as an oncological immunotherapeutic as well as a live vaccine vector against other pathogens. However, BCG vaccination has limite...
Autores principales: | Dellagostin, Odir Antônio, Borsuk, Sibele, Oliveira, Thaís Larré, Seixas, Fabiana Kömmling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146772/ https://www.ncbi.nlm.nih.gov/pubmed/35632558 http://dx.doi.org/10.3390/vaccines10050802 |
Ejemplares similares
-
Stable expression of Mycobacterium bovis antigen 85B in
auxotrophic M. bovis bacillus Calmette-Guérin
por: Rizzi, Caroline, et al.
Publicado: (2017) -
Harnessing Mycobacterium bovis BCG Trained Immunity to Control Human and Bovine Babesiosis
por: Bastos, Reginaldo G., et al.
Publicado: (2022) -
Molecular typing of Mycobacterium bovis isolates: A review
por: Ramos, Daniela Fernandes, et al.
Publicado: (2014) -
Vaccination with a BCG Strain Overexpressing Ag85B Protects Cattle against Mycobacterium bovis Challenge
por: Rizzi, Caroline, et al.
Publicado: (2012) -
Expression of recombinant Mycobacterium bovis antigen 85B by Mycobacterium smegmatis mc(2)
por: Soares, Amanda, et al.
Publicado: (2014)